<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The SCL gene encodes a member of the helix-loop-helix (HLH) family of transcription factors and is reportedly involved in up to 25% of T-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We have surveyed over 120 primary human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> including <z:hpo ids='HP_0002861'>melanomas</z:hpo>, myeloid, and <z:hpo ids='HP_0005526'>lymphoid leukemias</z:hpo>, and other <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> without evidence of rearrangements involving SCL </plain></SENT>
<SENT sid="2" pm="."><plain>These results are further supported by low level expression of SCL in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (as assessed by a polymerase chain-reaction-based method) </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that rearrangement/translocation with subsequent activation of SCL occurs infrequently in myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002861'>melanomas</z:hpo> </plain></SENT>
</text></document>